SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences informs about updates on buy back

18 Jun 2026 Evaluate
Zydus Lifesciences has informed about submission of the post buyback public advertisement pertaining to buyback of not exceeding 87,30,158 fully paid-up equity shares having face value of Rs 1 each (Equity Shares) of Zydus Lifesciences at a price of Rs 1,260 per Equity Share for an aggregate amount not exceeding Rs 1100,00,00,000 (Buyback Size), on a proportionate basis through tender offer route (Buyback), pursuant to the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (Buyback Regulations).

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1074.30 12.80 (1.21%)
18-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.00
Dr. Reddys Lab 1267.80
Cipla 1355.80
Zydus Lifesciences 1074.30
Lupin 2327.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: